过敏诊断市场规模、份额、按产品类型、过敏原、测试类型和地区分類的成长分析 - 产业预测，2024-2031 年

2022 年全球过敏诊断市场规模约为 43 亿美元，高于 2023 年的 48 亿美元，预测期内（2024-2031 年）复合年增长率为 11%，到 2031 年将达到 111 亿美元。达到美元。

由于环境变化、污染和生活方式的改变，全球过敏性疾病盛行率在都市区和农村地区变得越来越普遍，这推动了过敏诊断市场的显着增长。越来越多地采用体外诊断 (IVD) 测试、对更准确、更快速的测试解决方案的需求以及患者和医疗保健专业人员的意识不断增强等因素正在推动市场扩张。此外，政府和卫生组织正在进行旨在提高人们对过敏的认识的宣传活动，这进一步推动了对诊断工具的需求。此外，高通量诊断系统和实验室自动化的发展等技术进步显着提高了诊断准确性和效率。然而，挑战包括过敏诊断测试的高成本以及新兴市场获得先进医疗保健的机会有限。市场上也见证了主要企业之间的策略性合併、收购和联盟，重点是丰富其诊断产品组合併扩大其地理覆盖范围。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价格分析
• 专利分析
• 价值链分析
• 供应链分析
• 贸易分析
• 技术分析
• 客户和购买标准分析

过敏诊断市场：依产品/服务分类

• 市场概况
• 消耗品
• 装置
  • 免疫检测分析仪
  • 光度计
  • 其他乐器
• 服务

过敏诊断市场：按测试类型

• 市场概况
• 体内测试
  • 皮肤点刺试验
  • 斑贴试验
  • 其他体内测试
• 体外试验

过敏诊断市场：依过敏原分类

• 市场概况
• 吸入性过敏原
• 食物过敏原
• 药物过敏原
• 其他过敏原

过敏诊断市场：依最终用户分类

• 市场概况
• 医院附设实验室和诊所
• 诊断实验室
• 学术研究所
• 其他最终用户

过敏诊断市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Danaher Corporation
• Siemens Healthineers Ag
• Eurofins Scientific
• Biomerieux Sa
• Romer Labs Division Holding Gmbh
• Hollisterstier Allergy
• Omega Diagnostics Group Plc
• Hycor Biomedical
• R-Biopharm Ag
• Astra Biotech Gmbh
• Erba Group
• Dst Diagnostische Systeme & Technologien Gmbh
• Dr. Fooke Laboratorien GmbH

Global Allergy Diagnostics Market size was valued at around 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024-2031).

The allergy diagnostics market is experiencing substantial growth driven by the rising prevalence of allergic diseases globally, which are becoming increasingly common in both urban and rural areas due to environmental changes, pollution, and lifestyle shifts. Factors like the increasing adoption of in-vitro diagnostic (IVD) tests, the demand for more accurate and quick testing solutions, and rising awareness among patients and healthcare professionals are pushing market expansion. Governments and health organizations are also implementing campaigns aimed at raising awareness about allergies, which is further driving demand for diagnostic tools. Additionally, technological advancements, such as the development of high-throughput diagnostic systems and automation in laboratories, are significantly improving diagnostic accuracy and efficiency. However, the high costs associated with allergy diagnostic tests and the limited access to advanced healthcare in emerging markets pose challenges. The market is also witnessing strategic mergers, acquisitions, and partnerships among key players, focusing on enhancing their diagnostic portfolios and expanding their geographical reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Diagnostics Market Segmental Analysiss

Global Allergy Diagnostics Market is segmented by product, allergen, test type, end user, and region. Based on Product, the market is segmented into Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers, Other Instruments), Services. Based on Allergens, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens. Based on Test type, the market is segmented into Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Allergy Diagnostics Market

One of the key drivers of the allergy diagnostics market is the increasing prevalence of allergic conditions, such as allergic rhinitis, asthma, food allergies, and skin allergies, worldwide. Rapid industrialization, urbanization, and rising pollution levels contribute to heightened allergen exposure, especially in urban areas. Environmental pollutants, such as particulate matter, pollen, and dust, are major triggers for allergic reactions, and their growing presence in both developed and developing nations is fueling demand for diagnostic tools. Moreover, lifestyle factors, including changes in diet, increased consumption of processed foods, and altered microbiomes, are playing a role in the surge of food allergies, particularly among children. This rising burden of allergies is creating an urgent need for early and accurate diagnosis, with governments and healthcare providers prioritizing the development and dissemination of advanced allergy testing technologies.

Restraints in the Global Allergy Diagnostics Market

Despite the market's growth potential, one of the significant restraints is the high cost of allergy diagnostic tests, which limits their widespread adoption, particularly in low- and middle-income countries. Allergy diagnostics, especially advanced techniques like molecular diagnostics and component-resolved diagnostics (CRD), often require sophisticated equipment and specialized training, leading to increased operational costs. These costs are passed on to patients, making the tests unaffordable for many, especially in regions with limited healthcare reimbursement systems. Even in developed markets, where healthcare systems are more robust, insurance coverage for allergy diagnostics can be inconsistent, leaving patients with substantial out-of-pocket expenses. As healthcare budgets tighten and cost-containment becomes a priority for many governments, the high cost of allergy diagnostics could hinder broader market penetration, particularly among the uninsured or underinsured populations.

Market Trends of the Global Allergy Diagnostics Market

One of the emerging trends in the allergy diagnostics market is the increasing use of point-of-care (POC) testing, which allows for faster and more convenient allergy testing outside traditional laboratory settings. POC tests offer significant advantages, including shorter turnaround times, ease of use, and the ability to perform tests in clinics or even at home, which is particularly valuable in remote or underserved areas with limited access to healthcare facilities. The rise of at-home testing kits for allergies, especially in the context of increasing consumer demand for personalized healthcare solutions, is driving this trend. Moreover, technological advancements are improving the accuracy and reliability of POC tests, making them comparable to conventional laboratory-based methods. This shift towards decentralized testing aligns with broader healthcare trends focusing on patient-centric care and improved accessibility. As this trend continues to evolve, it is expected to open new opportunities for market players to innovate and expand their diagnostic offerings.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Patent Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Trade Analysis
• Technology Analysis
• Customer & Buying Criteria Analysis

Allergy Diagnostics Market, By Product & Service

• Market Overview
• Consumables
• Instruments
  • Immunoassay Analyzers
  • Luminometers
  • Other Instruments
• Services

Allergy Diagnostics Market, By Test Type

• Market Overview
• In Vivo Tests
  • Skin Prick Tests
  • Patch Tests
  • Other In Vivo Tests
• In Vitro Tests

Allergy Diagnostics Market, By Allergen

• Market Overview
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Allergy Diagnostics Market, By End User

• Market Overview
• Hospital-Based Laboratories & Clinics
• Diagnostic Laboratories
• Academic Research Institutes
• Other End Users

Allergy Diagnostics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux Sa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hollisterstier Allergy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hycor Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astra Biotech Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dst Diagnostische Systeme & Technologien Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Fooke Laboratorien GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments